Publications
- Pre-transplant positron emission tomography in patients with relapsed Hodgkin lymphoma2011 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
- Prognostic markers in chronic lymphocytic leukemia2011 | Faculty of Medicine in Hradec Králové
- Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment +12007 | Faculty of Medicine in Hradec Králové
- Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study2024 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
- Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- A comprehensive assessment of lymphocyte subsets, their prognostic significance, and changes after first-line therapy administration in patients with chronic lymphocytic leukemia2023 | Faculty of Medicine in Hradec Králové
- The Role of Cryopreservation Techniques in Manufacturing, Transport, and Storage of Car-T Therapy Products2023 | Faculty of Medicine in Hradec Králové
- Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study2023 | Publication without faculty affiliation
Loading network view...